<!DOCTYPE html>
<html lang="en" dir="ltr">

<head>
  <meta charset="utf-8">
  <title>Konstantin's Personal Site</title>
</head>


<body>

<table cellspacing="50">
  <tr>
    <td><img src="Kotschenreuther_Photo-modified.png" alt="Konstantin Kotschenreuther Professional Photo" height=250 width=250></td>
    <td style="text-align:right">
       <h1>Konstantin Kotschenreuther</h1>
      <p><em><strong>Final Year Medical Student</strong> - University of Cologne, Germany</em>
      </p>
    </td>
  </tr>
</table>


  <p> German by passport, multinational at heart. <br><br> Grew up in Germany, Spain, Austria,
    England and the United States. Keen interest in everything life sciences, especially from
    an innovation and entrepreneurial perspective.<br><br>

    Research experience in the field of molecular immunology with numerous publications
    and international congress presentations.<br><br>

    Currently exploring the world of programming and artificial intelligence, with a
    focus on machine learning to better prepare for, and help shape, a digital future
    in the medical field. <br><br>
    Passionate golfer, runner and sourdough baker. (Check out my bakes on <a target="blank" href="https://www.instagram.com/backhuettn/">Instagram</a>)</p>
    <br> <a href="contact_details.html">Contact Me!</a>
  <hr size="3" noshade>

  <h3>Education</h3>

  <table width="820">

    <tr>
      <td><strong>University of Cologne</strong></td>
      <td style="text-align:right"><strong>Since 04/2016</strong></td>
    </tr>
    <tr>
      <td>6 Year Medical Degree <br> <ul>
        <li>Passed United States Medical Licensing Examination - Step 1, with <br> a score of 239 (11/2021)</li>
      </ul> </td>
    </tr>

    <tr>
      <td><strong>WHU - Otto Beisheim School of Management</strong></td>
      <td style="text-align:right"><strong>08/2015 - 12/2015</strong></td>
    </tr>
    <tr>
      <td>B.S. International Business Administration <br> <br>
        </td>
    </tr>
  </table>

  <hr size="3" noshade>

  <h3>Work Experience</h3>

  <table width="820">
    <tr>

    </tr>
    <tr>
      <td><strong>Fertilly, Berlin DE</strong></td>
      <td style="text-align:right"><strong>02/2021 - 05/2021</strong></td>
    </tr>
    <tr>
      <td>Entrepreneur in Residence, Healthcare Start-Up (<15 Employees)
        <br> <ul>
        <li>Ownership over company-wide recruiting efforts filling 4 out of 5 key positions ahead <br> of schedule</li>
        <li>Built a system to measure marketing ROI and impact for online ad campaigns, maintained <br>existing and created new ad-campaigns</li>
        <li>Implemented a web-based deposit solution for patients thereby significantly reducing <br>appointment no-shows</li>
      </ul> </td>
    </tr>

    <tr>
      <td><strong>Ministry of Health Cologne, Cologne DE</strong></td>
      <td style="text-align:right"><strong>03/2020 - 02/2021</strong></td>
    </tr>
    <tr>
      <td>Medical Attachment to Biomonitoring Unit<br>
        <ul>
          <li>
          Medical Student Team Lead (Oversaw 30 MD Students) tasked with initial assessment and <br> medical testing of suspected COVID patients
          </li>
          <li>Implemented route optimization solution increasing the maximum number of daily <br> patients seen by 40%</li>
      </ul> </td>
    </tr>

    <tr>
      <td><strong>University Hospital of Cologne, Cologne DE</strong></td>
      <td style="text-align:right"><strong>07/2019 - 03/2020</strong></td>
    </tr>
    <tr>
      <td>Doctoral Research Candidate (Dr. med.)<br>
        <ul>
          <li>
          Laboratory research in the field of Molecular Immunology focusing on the effect of <br> cannabinoids in rheumatic autoimmune disease
          </li>
          <li>Identified and solved a key protocol issue which was responsible for complete cessation <br> of the laboratory groups research activity for approx. 3 weeks</li>
      </ul> </td>
    </tr>
  </table>

  <hr size="3" noshade>

  <h3>Honors and Extra-Curriculars</h3>
  <ul>
    <li>Abstracts accepted for presentation at 2020 FOCIS Annual Meeting (Keynote Speaker: Dr. Anthony Fauci, Chief Medical Advisor to the US President) and 2020 Annual German Rheumatologist Congress</li>
    <li>Started a Sourdough Bakery Delivery service for friends and family with a “finish baking at home” concept as unique selling point</li>
  </ul>

  <hr size="3" noshade>

  <h3>Additional Skills</h3>
  
  <table width="850" text-align="center">
    <tr>
      <td><strong>English</strong></td>
      <td>⭐⭐⭐⭐⭐</td>
      <td><strong>Python</strong></td>
      <td>⭐⭐⭐</td>
    </tr>
    <tr>
      <td><strong>German</strong></td>
      <td>⭐⭐⭐⭐⭐</td>
      <td><strong>HTML</strong></td>
      <td>⭐⭐⭐</td>
    </tr>
    <tr>
      <td><strong>Spanish</strong></td>
      <td>⭐⭐⭐⭐</td>
      <td><strong>JavaScript</strong></td>
      <td>⭐⭐⭐</td>
    </tr>
    <tr>
      <td><strong>French</strong></td>
      <td>⭐⭐⭐</td>
      <td><strong>CSS</strong></td>
      <td>⭐⭐⭐</td>
    </tr>

  </table>

  <hr size="3" noshade>
  <h3>Scientific Publications</h3>
  <ul>
    <li>Yan S, Golumba-Nagy V, Kotschenreuther K et al. <br> <strong>Membrane-bound IL-6R is upregulated on Th17 cells and inhibits Treg cell migration by
        regulating post-translational modification of VASP in autoimmune arthritis</strong> <br> <em>Cellular and Molecular Life Sciences</em>, 16 Dec. 2021, DOI: <a target="blank" href="https://link.springer.com/article/10.1007/s00018-021-04076-2">10.1007/s00018-021-04076-2</a></li>
    <br>
    <li>Kotschenreuther K, Waqué I, Yan S et al. <br> <strong>Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases</strong> <br> <em>Cellular and Molecular Immunology</em>, 28 Apr. 2020, DOI:
      <a target="blank" href="https://www.nature.com/articles/s41423-020-0437-4">10.1038/s41423-020-0437-4</a></li>
      <br>
    <li>• Meyer A, Wittekind PS, Kotschenreuther K et al. <br> <strong>Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional
        and biological DMARDs but not by JAK inhibitors</strong> <br> <em>Annals of the Rehumatic Diseases</em>, 19 Nov. 2019, DOI: <a target="blank" href="https://ard.bmj.com/content/80/12/e196">10.1136/annrheumdis-2019-216576</a></li>
  </ul>
</body>

</html>
